Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

NCT00171470 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
August 31, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia